OpenEvidence, An AI-Powered ‘Brain Extender’ For Doctors, Doubles Valuation To $12B With $250M Series D
OpenEvidence, an AI platform for doctors, raised $250 million in a Series D funding round, doubling its valuation to $12 billion, as it continues to expand its AI-powered medical search engine used by over 40% of U.S. physicians. This funding highlights the significant rise in investment in AI-related healthcare, with global funding to AI health tech companies reaching $14 billion in 2025.
OpenEvidence's recent Series D funding round, which doubled its valuation to $12 billion, highlights the significant investor interest in AI-driven health tech startups. For someone tracking startup funding, especially in the AI healthcare sector, this serves as a strong signal to explore opportunities in this growing market. The ability of OpenEvidence to rapidly scale and attract substantial funding from top-tier investors like Thrive Capital, DST, and Sequoia Capital underscores the potential for high returns in similar ventures focusing on AI solutions for healthcare.